SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : ACMI - Accumed Inc.

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Cisco who wrote (1107)1/12/1998 10:57:00 PM
From: Sigmund  Read Replies (1) of 1894
 
Cisco, looks to me like what preceeds a heart transplant operation.......sourcing! Or perhaps a kind of scary neighbor in an apartment complex.....or both.

I'm ready for the next move up.

The sales to price ratios are interesting but a lot of the stocks in this sector really don't have sales yet or any appreciable sales. Remember the old saying....no earnings....no earnings surprises.

Cytec and to a lesser extent NeoPath are beginning to have sales and this may be more of a problem for their shareholders than it is a blessing at this point. If Cytec has disappointing sales it may hurt them more than good sales will help. They need to put a lot of selling expense dollars into gaining these sales at this point in their development so it is a two-edge sword.

I hope they have a good earnings report as I think this would help all of the stocks in this sector except possibly AccuCyte. But even a direct competitor would not benefit from questions about the size of the market and the rate of penetration. I think the fortunes of all of these companies are somewhat intertwined.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext